What do have to say now you smug & unethical Copaxone reps?

Quote






Remember that these drugs effect real people with a real disease. Be a bigger man and hope for any upcoming treatments to have positive results for the people suffering from MS.

You may also want to look at this from an unbiased view point. Oh wait, look! I can be biased too...

"And with the one oral option we have today, there has been a lot of concern over a possible risk for immune suppression and also an increased risk for cancer," added Zamvil, who was not a part of the current study team. "That does not seem to be the case with this new drug. So this appears to be a significant advance forward."
 






I guess the original poster is clueless?

First of all our Reps aren't smug and unethical. They are the best in the MS Marketplace, and were voted as the best in Neurology by the Medical community. So we are very sorry you have to work at Biogen or Novartis and try to make yourself feel better by coming to the Number 1 Neurology Company's Board.

Looks to me like the oral that Teva will have shortly should be a block buster based on efficacy, and more importantly safety, which the other orals can't match. Patients with MS don't like the idea of opportunistic infections from an oral pill that Novartis makes.

Now Novartis and Biogen Reps go back to your primary care company's boards and discuss how miserable you are at your company. We at Teva have the Number 1 injectible agent for MS and soon the Number 1 oral pill. Sorry if that makes you think we are smug, but we can't help being the best for the MS patient community.
 






This must be the most ethical and compliant company I have ever worked for. And if a rep who works here doesnt work or does something unethical Teva catches up fast and gets rid of them. This company has zero tolerance for lazy and unethical people.
 






Anonymous said:
I guess the original poster is clueless?

First of all our Reps aren't smug and unethical. They are the best in the MS Marketplace, and were voted as the best in Neurology by the Medical community. So we are very sorry you have to work at Biogen or Novartis and try to make yourself feel better by coming to the Number 1 Neurology Company's Board.

Looks to me like the oral that Teva will have shortly should be a block buster based on efficacy, and more importantly safety, which the other orals can't match. Patients with MS don't like the idea of opportunistic infections from an oral pill that Novartis makes.

Now Novartis and Biogen Reps go back to your primary care company's boards and discuss how miserable you are at your company. We at Teva have the Number 1 injectible agent for MS and soon the Number 1 oral pill. Sorry if that makes you think we are smug, but we can't help being the best for the MS patient community.
Click to expand...

ROFLMFAO!!!!!!!!!!!! What a joke!!!!
 






Anonymous said:
I guess the original poster is clueless?

First of all our Reps aren't smug and unethical. They are the best in the MS Marketplace, and were voted as the best in Neurology by the Medical community. So we are very sorry you have to work at Biogen or Novartis and try to make yourself feel better by coming to the Number 1 Neurology Company's Board.

Looks to me like the oral that Teva will have shortly should be a block buster based on efficacy, and more importantly safety, which the other orals can't match. Patients with MS don't like the idea of opportunistic infections from an oral pill that Novartis makes.

Now Novartis and Biogen Reps go back to your primary care company's boards and discuss how miserable you are at your company. We at Teva have the Number 1 injectible agent for MS and soon the Number 1 oral pill. Sorry if that makes you think we are smug, but we can't help being the best for the MS patient community.
Click to expand...

Give me a break. No MS patient is going to switch to an oral med which has been proven to be less effective than standard treatment (doesn't matter how "safe" it is). Like other smaller companies which have operated under the radar (not following PHARMA code guidelines), Teva's turn to be in the regulatory spotlight will be coming along. Be prepared!
 






Anonymous said:
I guess the original poster is clueless?

First of all our Reps aren't smug and unethical. They are the best in the MS Marketplace, and were voted as the best in Neurology by the Medical community. So we are very sorry you have to work at Biogen or Novartis and try to make yourself feel better by coming to the Number 1 Neurology Company's Board.

Looks to me like the oral that Teva will have shortly should be a block buster based on efficacy, and more importantly safety, which the other orals can't match. Patients with MS don't like the idea of opportunistic infections from an oral pill that Novartis makes.

Now Novartis and Biogen Reps go back to your primary care company's boards and discuss how miserable you are at your company. We at Teva have the Number 1 injectible agent for MS and soon the Number 1 oral pill. Sorry if that makes you think we are smug, but we can't help being the best for the MS patient community.
Click to expand...

More deep pockets than anything else and total a disregard for pharma guidelines. Smug and unethical are just extra. Cant wait for Sunshine to expose and list by $ amt the so called thought leaders. Copaxone is a #1 therapy that owes its status entirely on the fact that neuros are easily bought off and that patients will always come second. Teva marketing 101.
 






Anonymous said:
More deep pockets than anything else and total a disregard for pharma guidelines. Smug and unethical are just extra. Cant wait for Sunshine to expose and list by $ amt the so called thought leaders. Copaxone is a #1 therapy that owes its status entirely on the fact that neuros are easily bought off and that patients will always come second. Teva marketing 101.
Click to expand...

Wow, you are really out of touch with how Teva works. Teva is way too cheap to pay a decent $ amount to speakers and KOL's. It is a standing joke among them that they can make more money from a single talk for Novartis and Biogen than they get for three at Teva. Sorry Charlie!
 






Anonymous said:
Wow, you are really out of touch with how Teva works. Teva is way too cheap to pay a decent $ amount to speakers and KOL's. It is a standing joke among them that they can make more money from a single talk for Novartis and Biogen than they get for three at Teva. Sorry Charlie!
Click to expand...

Yeah right ahhhhh poor broke Teva. Teva and their honorarium based selling are being beaten at their own game? whats the world coming to! Not to worry you must be paying i.e. back channeling your neuros more than enough cash. The standing joke among desperate MS patients is how in the name of god did I end up on this every day injection crap when Novartis and Biogen are paying my neurologist 3x the Teva rate? Patients, remember them?
 












Top Bottom
Back
Quote